Billing A, Fröhlich D, Mialkowskyj O, Stokstad P, Schildberg F W
Chirurgische Klinik und Poliklinik, Klinikum Grosshadern, Ludwig-Maximilians-Universität, München.
Langenbecks Arch Chir. 1992;377(5):305-13. doi: 10.1007/BF00189477.
In order to define rational criteria for "planned relaparotomies" (PR) in the treatment of critical intra-abdominal infections we have analysed characteristics and the clinical course of 377 patients with diffuse peritonitis 152 of whom were treated by PR. More detailed prognostic aspects and data of the clinical course were prospectively investigated in 111 cases. Patient's age and an underlying malignoma revealed to be of prognostic significance in both univariate and multivariate analysis. The number of organs involved in septic organ failure during the treatment was a further indicator of risk. 40% of our patients, however, survived even an impairment of 5 organ-systems. The successful eradication of the source of peritonitis either with the 1st operation or only with consecutive operations resulted in a crucial difference of the mortality rate with 14% and 64% respectively. The failure to accomplish a definite operative resolution was accompanied by a mortality rate of 90%. The systematical application of PR facilitated control and completion of the eradication of the source of peritonitis. In one third of the patients treated by PR this technique led to early detection of relevant complications and adequate operative treatment. Patients in whom primarily a definitive eradication of the source of peritonitis had been accomplished did not benefit from PR. In patients with persisting or relapsing peritonitis, however, PR was accompanied by a 27% reduction of mortality.
为了确定治疗严重腹腔内感染时“计划性再次剖腹探查术”(PR)的合理标准,我们分析了377例弥漫性腹膜炎患者的特征及临床病程,其中152例接受了PR治疗。对111例患者的临床病程进行了更详细的预后分析及前瞻性研究。在单因素和多因素分析中,患者年龄及潜在恶性肿瘤均显示出预后意义。治疗期间发生感染性器官衰竭的受累器官数量是另一个风险指标。然而,我们40%的患者即使有5个器官系统受损仍存活。首次手术或仅通过后续手术成功根除腹膜炎病因,导致死亡率有显著差异,分别为14%和64%。未能实现明确的手术解决伴随着90%的死亡率。PR的系统应用有助于控制并完成腹膜炎病因的根除。在接受PR治疗的患者中,该技术使三分之一的患者早期发现相关并发症并得到了充分的手术治疗。那些最初已成功彻底根除腹膜炎病因的患者未从PR中获益。然而,在持续性或复发性腹膜炎患者中,PR使死亡率降低了27%。